Search
Taysha Gene Therapies Inc
TSHAAdd to Watchlist
6.650USD
-0.160-2.35%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.13BMarket Cap
LossP/E TTM
Taysha Gene Therapies Inc's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Taysha Gene Therapies Inc is 8.12, ranking 164 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -17.66, which is -129.01% below the recent high of 5.12 and -15.96% above the recent low of -20.47.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.